Evaluation of Assays for Measurement of Serum (Anti)oxidants in Hemodialysis Patients

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">Estimated % contribution to total FRAP</td><td align="center">Estimated % contribution to total TAS</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Uric acid</td><td align="center">60</td><td align="center">33</td></tr><tr><td align="left">Protein</td><td align="center">10</td><td align="center">53</td></tr><tr><td align="left">Bilirubin</td><td align="center">5</td><td align="center">2</td></tr><tr><td align="left">Ascorbic acid</td><td align="center">15</td><td align="center">5</td></tr><tr><td align="left"><i>α</i>-Tocopherol</td><td align="center">5</td><td align="center">2</td></tr><tr><td align="left">Others</td><td align="center">5</td><td align="center">5</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Relative contributions of individual plasma antioxidants to total FRAP and TAS values (data from literature).

BioMed Research International

tab3

Table 3

Table 3: Evaluation of Assays for Measurement of Serum (Anti)oxidants in Hemodialysis Patients 